Pharmaceutical intermediates

Milvexian Intermediates

6 pharmaceutical intermediates for Milvexian. Indication: Reduce the risk of Thrombosis, Ischemic Stroke, Atrial Fibrillation, Acute Coronary Syndrome (ACS).

提交项目 All intermediates

About Milvexian

Originator: Bristol Myers Squibb
Indication: Reduce the risk of Thrombosis, Ischemic Stroke, Atrial Fibrillation, Acute Coronary Syndrome (ACS)

Available intermediates

6 intermediates currently listed for Milvexian. Request specifications, documentation or a quotation for any item below.

Milvexian intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
(R)-2-methylbut-3-enoic acid	20626-49-7	/	/
(5R,9S)-9-amino-21-(difluoromethyl)-5-methyl-21H-3-aza-1(4,2)-pyridina-2(5,4)-pyrazolacyclononaphan-4-one	1802431-24-8	/	/
6-(5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl)pyrimidin-4-ol	1802430-55-2	/	/
Pyrimidine, 4-[5-chloro-2-[4-(trimethylsilyl)-1H-1,2,3-triazol-1-yl]phenyl]-6-methoxy-	1802430-53-0	/	/
Pyrimidine, 4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-methoxy-	1802430-54-1	/	/
tert-butyl(S)-(1-(4-chloropyridin-2-yl)but-3-en-1-yl)carbamate	1329171-69-8	/	/

Other programs under M

Maribavir Maxacalcitol Metoclopramide HCl Micafungin Sodium Mirogabalin besilate Molnupiravir Momelotinib Dihydrochloride Monohydrate Moxifloxacin hydrochloride

Building toward Milvexian?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →